from the United States Court of Appeals for the First Circuit
See other cases from the First Circuit.
Record returned to U.S.D.C. for District of New Hampshire.
Record returned to U.S.C.A. for 1st Circuit.
JUDGMENT ISSUED.
Judgment REVERSED. Alito, J., delivered the opinion of the Court, in which Roberts, C. J., and Scalia, Kennedy, and Thomas, JJ., joined. Breyer, J., filed a dissenting opinion, in which Kagan, J., joined. Sotomayor, J., filed a dissenting opinion, in which Ginsburg, J., joined.
Argued. For petitioner: Jay P. Lefkowitz, New York, N. Y.; and Anthony A. Yang, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondent: David C. Frederick, Washington, D. C.
Reply of petitioner Mutual Pharmaceutical Company, Inc. filed. (Distributed)
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED.
Letter noting amended corporate disclosure statement received from counsel for the petitioner. (DISTRIBUTED)
Brief amici curiae of Senator Tom Harkin and Representative Henry A. Waxman filed. (Distributed)
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.
Brief amici curiae of Public Law Scholars filed. (Distributed)
Brief amici curiae of Torts Professors filed. (Distributed)
Brief amici curiae of American Association for Justice and Public Justice filed. (Distributed)
Brief amici curiae of John and Tammy Gilbert, et al. filed.
Brief amici curiae of Former FDA Commissioners Dr. Donald Kennedy and Dr. David A. Kessler filed. (Distributed)
Brief amicus curiae of Dr. John T. Schulz, III filed. (Distributed)
Brief amicus curiae of Council of State Governments filed. (Distributed)
Brief of respondent Karen L. Bartlett filed. (Distributed)
CIRCULATED.
Record from U.S.D.C. for the District of New Hampshire is electronic. There are sealed documents in this record.
Brief amici curiae of Ranbaxy Pharmaceuticals Inc., et al. filed.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Brief amici curiae of Washington Legal Foundation, and Allied Educational Foundation filed.
Brief amici curiae of Chamber of Commerce of the United States of America, et al. filed.
Brief amicus curiae of Product Liability Advisory Council, Inc. filed.
Brief amicus curiae of the United States filed.
Brief amicus curiae of DRI filed.
Record received from the U.S.C.A for the First Circuit. (1 Box). Video and Text CD's of the Testimony and Video Deposition are on the P: Drive
Consent to the filing of amicus curiae briefs in support of either party or neither party received from counsel for the petitioner.
Brief of petitioner Mutual Pharmaceutical Company, Inc. filed.
Joint appendix filed (2 volumes). (Statement of costs received.)
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent.
SET FOR ARGUMEMT ON Tuesday, March 19, 2013
Petition GRANTED.
Reply of petitioner Mutual Pharmaceutical Company, Inc. filed. (Distributed)
Brief of respondent Karen L. Bartlett in opposition filed.
Order further extending time to file response to petition to and including October 31, 2012.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Brief amici curiae of Morton Grove Pharmaceuticals, Inc., et al. filed.
Order extending time to file response to petition to and including October 1, 2012.
Petition for a writ of certiorari filed. (Response due August 31, 2012)
Mutual Pharmaceutical Company, Inc., Petitioner, represented by Jay P. Lefkowitz
Karen L. Bartlett, Respondent, represented by Keith M. Jensen
Karen L. Bartlett, Respondent, represented by David C. Frederick
American Association for Justice and Public Justice, Amicus Curiae, represented by Andre M. Mura
Chamber of Commerce of the United States of America, et al., Amicus Curiae, represented by Bert W. Rein
DRI, Amicus Curiae, represented by Mary Massaron Ross
Dr. John T. Schulz, III, Amicus Curiae, represented by Erik S. Jaffe
Former FDA Commissioners Dr. Donald Kennedy and Dr. David A. Kessler, Amicus Curiae, represented by Jonathan S. Massey
Generic Pharmaceutical Association, Amicus Curiae, represented by Ray Manuel Aragon
Generic Pharmaceutical Association, Amicus Curiae, represented by Joseph P. Thomas
John and Tammy Gilbert, et al., Amicus Curiae, represented by Louis M. Bograd
Morton Grove Pharmaceuticals, Inc., et al., Amicus Curiae, represented by Steffen N. Johnson
Mutual Pharmaceutical Company, Inc. v. Karen L. Bartlett, Amicus Curiae, represented by Anthony Alan Yang
Product Liability Advisory Council, Inc., Amicus Curiae, represented by David R. Geiger
Public Law Scholars, Amicus Curiae, represented by Ernest A. Young
Ranbaxy Pharmaceuticals Inc., et al., Amicus Curiae, represented by Steffen Nathanael Johnson
Senator Tom Harkin and Representative Henry A. Waxman, Amicus Curiae, represented by Allison M. Zieve
the United States, Amicus Curiae, represented by Donald B. Verrilli Jr.
Torts Professors, Amicus Curiae, represented by Michael F. Sturley
Washington Legal Foundation, and Allied Educational Foundation, Amicus Curiae, represented by Richard A. Samp